Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 99 citing articles:

Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)
Balamurugan Shanmugaraj, Konlavat Siriwattananon, Kittikhun Wangkanont, et al.
Asian Pacific Journal of Allergy and Immunology (2020)
Open Access | Times Cited: 483
Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
Guangyu Zhou, Qi Zhao
International Journal of Biological Sciences (2020) Vol. 16, Iss. 10, pp. 1718-1723
Open Access | Times Cited: 274
Updated Approaches against SARS-CoV-2
Hai-Ou Li, Yunjiao Zhou, Meng Zhang, et al.
Antimicrobial Agents and Chemotherapy (2020) Vol. 64, Iss. 6
Open Access | Times Cited: 271
Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy In Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use
Laxmaiah Manchikanti
Pain Physician (2020) Vol. 2;23, Iss. 4;2, pp. E71-E83
Open Access | Times Cited: 229
Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs
Dharma Rao Tompa, Aruldoss Immanuel, Srimari Srikanth, et al.
International Journal of Biological Macromolecules (2021) Vol. 172, pp. 524-541
Open Access | Times Cited: 190
Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications
Nehla Banu, Sandeep Surendra Panikar, Lizbeth Riera Leal, et al.
Life Sciences (2020) Vol. 256, pp. 117905-117905
Open Access | Times Cited: 181
COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches
Francesco Moccia, Andrea Gerbino, Vincenzo Lionetti, et al.
GeroScience (2020) Vol. 42, Iss. 4, pp. 1021-1049
Open Access | Times Cited: 159
Potential role of ACE2 in coronavirus disease 2019 (COVID-19) prevention and management
Mengyuan Liu, Ting Wang, Yun Zhou, et al.
Journal of Translational Internal Medicine (2020) Vol. 8, Iss. 1, pp. 9-19
Open Access | Times Cited: 132
Penggunaan Desinfektan dan Antiseptik Pada Pencegahan Penularan Covid-19 di Masyarakat
Annisa Lazuardi Larasati, Dolih Gozali, Chandra Haribowo
Majalah Farmasetika (2020) Vol. 5, Iss. 3
Open Access | Times Cited: 99
The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2
Erik Procko
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 97
Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future
Swaminathan Sethu, Rohit Shetty, Arkasubhra Ghosh, et al.
Indian Journal of Ophthalmology (2020) Vol. 68, Iss. 5, pp. 693-693
Open Access | Times Cited: 87
Withanone from Withania somnifera May Inhibit Novel Coronavirus (COVID-19) Entry by Disrupting Interactions between Viral S-Protein Receptor Binding Domain and Host ACE2 Receptor
Acharya Balkrishna, Subarna Pokhrel, Jagdeep Singh, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 80
Potential therapeutic targets and promising drugs for combating SARS‐CoV‐2
Hong Zhou, Fang Yan, Tao Xu, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 14, pp. 3147-3161
Open Access | Times Cited: 79
Initial success in the identification and management of the coronavirus disease 2019 (COVID-19) indicates human-to-human transmission in Wuhan, China
Annoor Awadasseid, Yanling Wu, Yoshimasa Tanaka, et al.
International Journal of Biological Sciences (2020) Vol. 16, Iss. 11, pp. 1846-1860
Open Access | Times Cited: 72
Development and application of therapeutic antibodies against COVID-19
Lin Ning, Hamza B. Abagna, Qianhu Jiang, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 6, pp. 1486-1496
Open Access | Times Cited: 58
Approaches towards fighting the COVID‑19 pandemic (Review)
Shih‐Chang Tsai, Chi‐Cheng Lu, DA-TIAN BAU, et al.
International Journal of Molecular Medicine (2020) Vol. 47, Iss. 1, pp. 3-22
Open Access | Times Cited: 68
Virtual Screening Based Prediction of Potential Drugs for COVID-19
Sekhar Talluri
(2020)
Open Access | Times Cited: 60
Development and simulation of fully glycosylated molecular models of ACE2-Fc fusion proteins and their interaction with the SARS-CoV-2 spike protein binding domain
Austen Bernardi, Yihan Huang, Bradley Harris, et al.
PLoS ONE (2020) Vol. 15, Iss. 8, pp. e0237295-e0237295
Open Access | Times Cited: 57
Gene editing and RNAi approaches for COVID-19 diagnostics and therapeutics
Burak Berber, Cihan Aydın, Fatih Kocabaş, et al.
Gene Therapy (2020) Vol. 28, Iss. 6, pp. 290-305
Open Access | Times Cited: 44
Inhibitory efficiency of potential drugs against SARS-CoV-2 by blocking human angiotensin converting enzyme-2: Virtual screening and molecular dynamics study
Abdul Ashik Khan, Nabajyoti Baildya, Tanmoy Dutta, et al.
Microbial Pathogenesis (2021) Vol. 152, pp. 104762-104762
Open Access | Times Cited: 34
Microfluidic-based technologies for diagnosis, prevention, and treatment of COVID-19: recent advances and future directions
E. Alperay Tarim, Müge Anıl-İnevi, Ilayda Ozkan, et al.
Biomedical Microdevices (2023) Vol. 25, Iss. 2
Open Access | Times Cited: 16
miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis
Rohit Satyam, Tulika Bhardwaj, Sachin Goel, et al.
Current Pharmaceutical Design (2020) Vol. 27, Iss. 13, pp. 1628-1641
Closed Access | Times Cited: 37
Drug Repositioning Suggests a Role for the Heat Shock Protein 90 Inhibitor Geldanamycin in Treating COVID-19 Infection
Iyad Sultan, Scott C. Howard, Abdelghani Tbakhi
Research Square (Research Square) (2020)
Closed Access | Times Cited: 35
The emerging role of miRNAs in the pathogenesis of COVID-19: Protective effects of nutraceutical polyphenolic compounds against SARS-CoV-2 infection
Chih-Yun Yang, Yu‐Hsuan Chen, Pei-Jung Liu, et al.
International Journal of Medical Sciences (2022) Vol. 19, Iss. 8, pp. 1340-1356
Open Access | Times Cited: 22
Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic
Pooja Kaushik, Medha Kaushik, Sabiha Parveen, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 12, pp. 4921-4928
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top